Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-07-03 16:00:40
Reporting Period:
Accepted Time:
2018-07-03 16:00:40
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1426800 Assembly Biosciences Inc. ASMB () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238325 R William Ringo C/o Assembly Biosciences, Inc.
11711 N. Meridian Street, Suite 310
Carmel IN 46032
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-02 1,000 $7.20 20,465 No 4 M Direct
Common Stock Disposition 2018-07-02 1,000 $38.50 19,465 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-07-02 1,000 $0.00 1,000 $7.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
49,000 2024-07-10 No 4 M Direct
  1. The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.515, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
  3. This option, initially representing a right to purchase 64,000 shares, became exercisable in three equal installments on July 11, 2014; July 11, 2015; and July 11, 2016.